Disorders Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

Disorders Stocks Recent News

Date Stock Title
May 10 BAX A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts
May 10 BAX Baxter downgraded to hold by TD Cowen in wake of selloff
May 10 OMER Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
May 9 NBIX How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
May 9 NBIX Neurocrine Biosciences Presents CAHtalystâ„¢ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024
May 9 PHAT Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates
May 9 OMER Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
May 9 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1076986 in Healthy Adults
May 9 PHAT Phathom Pharmaceuticals Non-GAAP EPS of -$1.11 beats by $0.06, revenue of $1.91M misses by $0.23M
May 9 FULC Fulcrum Therapeutics to Participate in Upcoming May Conferences
May 9 PHAT Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 9 ITCI Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What Analysts Think
May 9 IONS The Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 8 ITCI Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
May 8 IONS Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript
May 8 IONS Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
May 8 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
May 8 FULC Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology
May 8 ITCI Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
May 8 IONS Ionis Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Disorders

Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

Browse All Tags